Table 1.
Patients’ characteristics.
| No.* | Mean age# (SD) |
Male (%) |
No. of tested mSEPT9** | No. of tested CEA** | |
|---|---|---|---|---|---|
| Colorectal Cancer | 117 | 67.3 (12.8) | 80 (68.4%) | 112 | 110 |
| Stage I | 20 | 67.2 (10.1) | 15 (75.0%) | 19 | 19 |
| Stage II | 47 | 69.6 (12.8) | 32 (68.1%) | 46 | 45 |
| Stage III | 35 | 66.1 (13.4) | 23 (65.7%) | 33 | 32 |
| Stage IV | 4 | 69.8 (8.3) | 3 (75.0%) | 4 | 4 |
| Unknown | 11 | 60.6 (15.7) | 7 (63.6%) | 10 | 10 |
| Colorectal Adenoma | 95 | 66.8 (9.0) | 58 (61.1%) | 92 | 90 |
| Advanced | 45 | 67.3 (8.6) | 31 (68.9%) | 43 | 40 |
| Non-advanced | 50 | 66.4 (9.5) | 27 (54.0%) | 49 | 50 |
| Normal | 70 | 63.1 (11.7) | 39 (55.7%) | 69 | 58 |
| Total | 282 | 66.1 (11.5) | 177 (62.8%) | 273 | 258 |
*No. means the number of cases.
#Age was calculated at the time of diagnosing.
**No. means the number of cases which had results of mSEPT9 (methylated septin 9) or CEA (carcinoembryonic antigen), and the corresponding sensitivity was shown in Fig. 2.